smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Munich
State: Bayern
Zip:
Country: Germany
smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2023 | Seed Round | $0 |
Boehringer Ingelheim Venture Fund High-Tech Grunderfonds Boehringer Ingelheim Venture Fund High-Tech Grunderfonds Boehringer Ingelheim Venture Fund High-Tech Grunderfonds Boehringer Ingelheim Venture Fund High-Tech Grunderfonds |
5/2023 | Pre Seed Round | $0 |
Boehringer Ingelheim Venture Fund Boehringer Ingelheim Venture Fund Boehringer Ingelheim Venture Fund Boehringer Ingelheim Venture Fund |
5/2023 | Seed Round | 2 | $1.3M |
Boehringer Ingelheim Venture Fund High-Tech Grunderfonds Boehringer Ingelheim Venture Fund High-Tech Grunderfonds |
5/2023 | Pre Seed Round | 1 | $756k |
Boehringer Ingelheim Venture Fund Boehringer Ingelheim Venture Fund |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|